Medication Adherence Program | MicrobiomeTrials← Back to trialsNCT05183763
Medication Adherence Program
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-03-07Est. Completion: 2027-04-30
Enrollment target: 402 participants Locations- Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States
- Tulane Doctors Dermatology & Multispecialty Clinic, Covington, Louisiana, United States
- Tulane Doctors Heart & Vascular and Primary Care Clinic, Metairie, Louisiana, United States
- Tulane University Clinical and Translational Unit, New Orleans, Louisiana, United States
- LSU Health Sciences Shreveport Clinical Trials Office, Shreveport, Louisiana, United States
Other microbiome trials you might be interested in
Heart Failure
Background:
More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…
Falls Church, United StatesCompleted Apr 30, 2028
Peritoneal Mesothelioma
Official Title: A Study of Key Parameters and Mechanisms in Personalized Diagnosis and Treatment Using Tumor Models
Why…
Beijing, ChinaEst. completion Nov 1, 2029
Chronic Obstructive Pulmonary Disease (COPD)
Asthma (Diagnosis)
Interstitial Lung Disease (ILD)
Bronchiectasis
Breathing Pattern Disorder
Breathlessness is a complex symptom that results in poor quality of life, increased hospitalisations and increased morta…
Leicester, United KingdomEst. completion Jul 1, 2026